查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1822423

2032 年注意力不足過動症和自閉症數位治療市場預測：按產品、年齡層、治療重點、交付模式、最終用戶和地區進行的全球分析

Digital Therapeutics for ADHD & Autism Market Forecasts to 2032 - Global Analysis By Product (Software Applications, Devices (Wearables) and Platforms (Telehealth Solutions)), Age Group, Therapeutic Focus, Delivery Mode, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球注意力不足過動症和自閉症數位療法市場規模預計在 2025 年達到 13 億美元，到 2032 年將達到 54 億美元，預測期內的複合年成長率為 21.7%。

針對注意力不足過動症 (ADHD) 和自閉症的數位療法 (DTx) 是基於循證的、軟體驅動的主導，旨在預防、管理和治療這些神經發育障礙的症狀。 DTx 利用應用程式、電玩遊戲和互動式等數位平台來提高注意力、認知靈活性、情緒調節和社交技能。 DTx 是傳統治療方法的補充，提供個人化、引人入勝且擴充性的治療方法。這些數位解決方案經過臨床檢驗，通常由醫療保健專業人員開立處方，可提供持續監測、自適應學習和行為回饋，以改善患者預後，同時減少對藥物的依賴並支持長期發展進步。

數位健康的科技進步

數位療法可實現個人化介入、即時進度追蹤和遠端互動。與行為分析、言語治療和認知訓練的結合正在改善治療效果。學校、診所和看護者正在採用科技工具來支持神經病變患者。公共和私營部門對數位醫療基礎設施的投資正在增強其應用。這些動態使數位創新成為過動症和自閉症治療市場的關鍵驅動力，並推動整體市場成長。

監管和報銷挑戰

開發者面臨著許多挑戰，例如獲得核准、檢驗臨床有效性以及遵守資料隱私法。付款方對非傳統治療方法的承保持謹慎態度，這影響了其可及性。數位健康政策和核准的地區差異使部署變得複雜。缺乏標準化的結果指標阻礙了可擴展性和信任。儘管技術發展勢頭強勁，但這些因素仍在限制市場擴張。

擴大投資和市場潛力

創業投資、政府津貼和策略夥伴關係正在加速產品開發和平台整合。教育機構、雇主和醫療保健提供者正在投資擴充性且依證的數位解決方案。對非侵入性、個人化和便利治療方法的需求正在推動創新。公共衛生計劃和全面的教育要求正在推動數位療法的普及。這些新興市場的發展為市場成長創造了有利條件，並加速了數位療法的普及。

成本和可訪問性問題

數位素養差距和基礎設施限制影響用戶參與度和留存率。服務提供者必須投資在地化、可負擔性和混合交付模式，以克服障礙。網路存取和設備可用性方面的差異降低了農村和服務欠缺地區的採用率。與傳統護理途徑的整合有限，減緩了臨床應用。這些限制構成系統性風險，並限制了全面的市場發展。

COVID-19的影響：

新冠疫情擾亂了注意力不足過動症 (ADHD) 和自閉症數位療法市場，導致臨床檢驗、平台部署和現場評估暫時延遲。教育機構、治療中心和診斷實驗室的容量減少影響了護理的連續性。然而，對心理健康、遠端參與和數位優先干涉措施的關注度增加部分抵消了市場放緩的影響。疫情後的復甦得益於對可訪問、技術支援和個人化神經發育支援解決方案的需求成長，以及各個使用者群體在虛擬治療平台和居家干預方面的創新。

預計軟體應用領域將成為預測期內最大的領域

軟體應用領域預計將在預測期內佔據最大的市場佔有率，這得益於其擴充性、成本效益以及跨裝置和平台的便利整合。行動應用程式、基於網路的工具和人工智慧主導的介面正在實現即時監控、自適應學習和行為強化。供應商正在最佳化演算法，以提供針對特定年齡、適應文化並經過臨床檢驗的干涉措施。醫療保健、教育和居家照護領域的需求仍然強勁。監管部門對數位健康和​​數據互通性的支持正在推動其應用。該領域將繼續支持數位治療市場，推動整體市場成長。

預計教育領域在預測期內將以最高的複合年成長率成長

預計教育領域將在預測期內實現最高成長率，這得益於對神經病變學生全面、技術賦能和可擴展支援的需求。學校正在採用數位治療方法來改善學習成果、減少行為障礙並支持個人化教育計畫。與課堂工具、教師儀表板和學生進度追蹤器的整合正在提高學生的參與度和課責。特殊教育的公共資金和政策授權正在加速其應用。對基於證據的、可訪問的解決方案的需求正在積聚勢頭，加速市場擴張。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的數位健康生態系統、強大的報銷基礎設施以及對神經發育障礙的高度認知。美國和加拿大在臨床檢驗、平台部署和監管核准處於主導地位。心理健康、全納教育和數位療法領域的公共舉措正在增強需求。區域新興企業和學術機構正在推動人工智慧、使用者體驗設計和治療內容的創新。保險覆蓋和學校項目正在支持相關技術的採用。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高，這得益於兒科人口的成長、數位基礎設施的擴展以及政府對神經發育護理的投入。中國、印度、日本和韓國等國家正在擴大學校篩檢、行動醫療平台和全納教育計畫。官民合作關係和行動優先策略正在改善都市區和半都市區的醫療服務可近性。對價格合理、文化適應性強且多語言工具的需求正在推動創新。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球注意力不足過動症和自閉症數位治療市場（按產品）

  • 軟體應用程式
  • 裝置（穿戴式裝置）
  • 平台（遠端醫療解決方案）

6. 全球注意力不足過動症和自閉症數位治療市場（按年齡層）

  • 孩子
  • 青年
  • 成人

7. 全球注意力不足過動症和自閉症數位治療市場（按治療重點）

  • 認知行為治療（CBT）
  • 社交技能培訓
  • 注意力訓練
  • 睡眠管理
  • 焦慮和壓力管理

8. 全球注意力不足過動症和自閉症數位治療市場（按交付模式）

  • 行動應用程式
  • 網路為基礎的平台
  • 虛擬實境（VR）
  • 擴增實境（AR）

9. 全球注意力不足過動症和自閉症數位治療市場（按最終用戶分類）

  • 個人
  • 醫療保健提供者
  • 教育機構
  • 看護者和家人
  • 雇主和職場
  • 其他最終用戶

10. 全球注意力不足過動症和自閉症數位治療市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第 12 章：公司概況

  • Cognoa Inc.
  • Akili, Inc.
  • Pear Therapeutics, Inc.
  • CogniFit Inc.
  • BrainWare Learning Company
  • Neurocog Trials, Inc.
  • Headspace Health
  • Mightier
  • Elemy Health
  • Floreo Inc.
  • NeuroFlow Inc.
  • Limbix Health, Inc.
  • Total Brain
  • Koa Health
  • Bold Health
Product Code: SMRC31178

According to Stratistics MRC, the Global Digital Therapeutics for ADHD & Autism Market is accounted for $1.3 billion in 2025 and is expected to reach $5.4 billion by 2032 growing at a CAGR of 21.7% during the forecast period. Digital Therapeutics (DTx) for ADHD and Autism are evidence-based, software-driven interventions designed to prevent, manage, or treat symptoms of these neurodevelopmental disorders. Utilizing digital platforms such as apps, video games, and interactive programs, DTx aim to improve attention, cognitive flexibility, emotional regulation, and social skills. They complement traditional therapies, providing personalized, engaging, and scalable treatment options. Clinically validated and often prescribed by healthcare professionals, these digital solutions offer continuous monitoring, adaptive learning, and behavioral feedback, enhancing patient outcomes while reducing reliance on medication and supporting long-term developmental progress.

Market Dynamics:

Driver:

Technological advancements in digital health

Digital therapeutics are enabling personalized interventions, real-time progress tracking, and remote engagement. Integration with behavioral analytics, speech therapy, and cognitive training is enhancing treatment outcomes. Schools, clinics, and caregivers are adopting tech-enabled tools to support neurodiverse individuals. Public and private investments in digital health infrastructure are reinforcing adoption. These dynamics are positioning digital innovation as a key driver of the ADHD & autism therapeutics market, thereby boosting overall market growth.

Restraint:

Regulatory and reimbursement challenges

Developers face hurdles in securing approvals, validating clinical efficacy, and navigating data privacy laws. Payers remain cautious about coverage for non-traditional interventions, affecting accessibility. Regional disparities in digital health policy and licensing are complicating deployment. Lack of standardized outcome metrics is hindering scalability and trust. These factors are tempering market expansion despite strong technological momentum.

Opportunity:

Growing investment and market potential

Venture capital, government grants, and strategic partnerships are accelerating product development and platform integration. Educational institutions, employers, and healthcare providers are investing in scalable, evidence-based digital solutions. Demand for non-invasive, personalized, and accessible therapies is reinforcing innovation. Public health initiatives and inclusive education mandates are supporting adoption. These developments are creating favorable conditions for market growth, thereby accelerating uptake of digital therapeutics.

Threat:

Cost and accessibility issues

Digital literacy gaps and infrastructure constraints are affecting user engagement and retention. Providers must invest in localization, affordability, and hybrid delivery models to overcome barriers. Disparities in internet access and device availability are reducing reach in rural and underserved regions. Limited integration with traditional care pathways is slowing clinical adoption. These limitations are introducing systemic risk and constraining full-scale market development.

Covid-19 Impact:

The Covid-19 pandemic disrupted the Digital Therapeutics for ADHD & Autism market, causing temporary delays in clinical validation, platform deployment, and in-person assessments. Educational institutions, therapy centers, and diagnostic facilities experienced reduced capacity, impacting continuity of care. However, the increased focus on mental health, remote engagement, and digital-first interventions partially offset the slowdown. Post-pandemic recovery is driven by growing demand for accessible, tech-enabled, and personalized neurodevelopmental support solutions, along with innovations in virtual therapy platforms and home-based interventions across user segments.

The software applications segment is expected to be the largest during the forecast period

The software applications segment is expected to account for the largest market share during the forecast period owing to its scalability, cost-efficiency, and ease of integration across devices and platforms. Mobile apps, web-based tools, and AI-driven interfaces are enabling real-time monitoring, adaptive learning, and behavioural reinforcement. Providers are optimizing algorithms for age-specific, culturally adaptive, and clinically validated interventions. Demand remains strong across healthcare, education, and homecare domains. Regulatory support for digital health and data interoperability is reinforcing adoption. This segment continues to anchor the digital therapeutics market, thereby boosting overall market growth.

The educational institutions segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the educational institutions segment is predicted to witness the highest growth rate driven by demand for inclusive, tech-enabled, and scalable support for neurodiverse students. Schools are adopting digital therapeutics to enhance learning outcomes, reduce behavioural disruptions, and support individualized education plans. Integration with classroom tools, teacher dashboards, and student progress trackers is improving engagement and accountability. Public funding and policy mandates for special education are accelerating deployment. Demand for evidence-based, accessible solutions is reinforcing momentum, thereby accelerating market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced digital health ecosystem, strong reimbursement infrastructure, and high awareness of neurodevelopmental conditions. The U.S. and Canada are leading in clinical validation, platform deployment, and regulatory approvals. Public initiatives in mental health, inclusive education, and digital therapeutics are reinforcing demand. Regional startups and academic institutions are driving innovation in AI, UX design, and therapeutic content. Insurance coverage and school-based programs are supporting widespread adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising paediatric population, expanding digital infrastructure, and government investment in neurodevelopmental care. Countries like China, India, Japan, and South Korea are scaling school-based screening, mobile health platforms, and inclusive education programs. Public-private partnerships and mobile-first strategies are improving access in urban and semi-urban areas. Demand for affordable, culturally adaptive, and multilingual tools is reinforcing innovation.

Key players in the market

Some of the key players in Digital Therapeutics for ADHD & Autism Market include Cognoa Inc., Akili, Inc., Pear Therapeutics, Inc., CogniFit Inc., BrainWare Learning Company, Neurocog Trials, Inc., Headspace Health, Mightier, Elemy Health, Floreo Inc., NeuroFlow Inc., Limbix Health, Inc., Total Brain, Koa Health and Bold Health.

Key Developments:

In July 2025, Cognoa expanded partnerships with Highmark Health and HTAhealth, enabling broader access to its AI-powered autism diagnostic, Canvas Dx, for self-insured employers and commercial health plans. These collaborations support scalable deployment and reimbursement of digital diagnostics across pediatric populations.

In March 2024, Akili entered a strategic partnership with Shionogi & Co. Ltd. to commercialize its ADHD and autism digital therapeutics in Japan and Taiwan, with milestone payments up to $125M. Shionogi will lead clinical development and marketing, while Akili manages global platform operations and data compliance.

Products Covered:

  • Software Applications
  • Devices (Wearables)
  • Platforms (Telehealth Solutions)

Age Groups Covered:

  • Children
  • Adolescents
  • Adults

Therapeutic Focuses Covered:

  • Cognitive Behavioural Therapy (CBT)
  • Social Skills Training
  • Attention Training
  • Sleep Management
  • Anxiety and Stress Management

Delivery Modes Covered:

  • Mobile Applications
  • Web-Based Platforms
  • Virtual Reality (VR)
  • Augmented Reality (AR)

End Users Covered:

  • Individuals
  • Healthcare Providers
  • Educational Institutions
  • Caregivers and Families
  • Employers & Workplace
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Therapeutics for ADHD & Autism Market, By Product

  • 5.1 Introduction
  • 5.2 Software Applications
  • 5.3 Devices (Wearables)
  • 5.4 Platforms (Telehealth Solutions)

6 Global Digital Therapeutics for ADHD & Autism Market, By Age Group

  • 6.1 Introduction
  • 6.2 Children
  • 6.3 Adolescents
  • 6.4 Adults

7 Global Digital Therapeutics for ADHD & Autism Market, By Therapeutic Focus

  • 7.1 Introduction
  • 7.2 Cognitive Behavioral Therapy (CBT)
  • 7.3 Social Skills Training
  • 7.4 Attention Training
  • 7.5 Sleep Management
  • 7.6 Anxiety and Stress Management

8 Global Digital Therapeutics for ADHD & Autism Market, By Delivery Mode

  • 8.1 Introduction
  • 8.2 Mobile Applications
  • 8.3 Web-Based Platforms
  • 8.4 Virtual Reality (VR)
  • 8.5 Augmented Reality (AR)

9 Global Digital Therapeutics for ADHD & Autism Market, By End User

  • 9.1 Introduction
  • 9.2 Individuals
  • 9.3 Healthcare Providers
  • 9.4 Educational Institutions
  • 9.5 Caregivers and Families
  • 9.6 Employers & Workplace
  • 9.7 Other End Users

10 Global Digital Therapeutics for ADHD & Autism Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Cognoa Inc.
  • 12.2 Akili, Inc.
  • 12.3 Pear Therapeutics, Inc.
  • 12.4 CogniFit Inc.
  • 12.5 BrainWare Learning Company
  • 12.6 Neurocog Trials, Inc.
  • 12.7 Headspace Health
  • 12.8 Mightier
  • 12.9 Elemy Health
  • 12.10 Floreo Inc.
  • 12.11 NeuroFlow Inc.
  • 12.12 Limbix Health, Inc.
  • 12.13 Total Brain
  • 12.14 Koa Health
  • 12.15 Bold Health

List of Tables

  • Table 1 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Software Applications (2024-2032) ($MN)
  • Table 4 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Devices (Wearables) (2024-2032) ($MN)
  • Table 5 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Platforms (Telehealth Solutions) (2024-2032) ($MN)
  • Table 6 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 7 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Children (2024-2032) ($MN)
  • Table 8 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Adolescents (2024-2032) ($MN)
  • Table 9 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Adults (2024-2032) ($MN)
  • Table 10 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Therapeutic Focus (2024-2032) ($MN)
  • Table 11 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Cognitive Behavioral Therapy (CBT) (2024-2032) ($MN)
  • Table 12 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Social Skills Training (2024-2032) ($MN)
  • Table 13 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Attention Training (2024-2032) ($MN)
  • Table 14 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Sleep Management (2024-2032) ($MN)
  • Table 15 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Anxiety and Stress Management (2024-2032) ($MN)
  • Table 16 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Delivery Mode (2024-2032) ($MN)
  • Table 17 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Mobile Applications (2024-2032) ($MN)
  • Table 18 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Web-Based Platforms (2024-2032) ($MN)
  • Table 19 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Virtual Reality (VR) (2024-2032) ($MN)
  • Table 20 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Augmented Reality (AR) (2024-2032) ($MN)
  • Table 21 Global Digital Therapeutics for ADHD & Autism Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Individuals (2024-2032) ($MN)
  • Table 23 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Healthcare Providers (2024-2032) ($MN)
  • Table 24 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Educational Institutions (2024-2032) ($MN)
  • Table 25 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Caregivers and Families (2024-2032) ($MN)
  • Table 26 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Employers & Workplace (2024-2032) ($MN)
  • Table 27 Global Digital Therapeutics for ADHD & Autism Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.